Medable

Directions Website

Medable Medable is on a mission to reduce clinical trial times by 50%, Streamlining digital trials and enabl Medable is the platform for healthcare.

Medable started with an API for automating health app development so applications meet HIPAA regulations. Medable has since expanded into a complete platform for healthcare that caters to the healthcare sector’s strict compliance, interoperability, and privacy concerns worldwide. Medable has the most complete end-to-end solution and richest feature offering on the digital healthcare market. Using Medable’s platform, a single developer can quickly develop and deploy a full-stack HIPAA compliant app to serve any healthcare use case. Apps powered by Medable securely collect, store, and analyze protected health data.

10/23/2026

Come see what's possible in the age of agentic trial operations at Medable.com.

10/05/2026

Clinical monitoring is entering a new era. And this one moves fast.

Medable’s latest monitoring agents work across the day-to-day realities of clinical monitoring: prioritizing site risk, preparing visits, recommending next actions, automating administrative work, and helping CRAs focus their time where human judgment matters most.

And we’re already seeing the impact. In two studies, the Clinical Monitoring Agent delivered a 62% reduction in CRA task time in one deployment and a 90% reduction in visit report preparation in another.

This Breast Cancer Awareness Month, we recognize every patient, family, researcher, clinician, and advocate whose life a...
10/02/2026

This Breast Cancer Awareness Month, we recognize every patient, family, researcher, clinician, and advocate whose life and work are connected to this disease.

Because behind every study, every breakthrough, and every day we work to give back to clinical development, there are people hoping for more time and better options. 🩷

At Medable, our mission is to make clinical trials faster, more accessible, and more effective, so promising science can reach the people waiting for it sooner.

AI agents evolve. Medable’s agentic governance evolves with them.Our continuous governance framework monitors agent perf...
09/28/2026

AI agents evolve. Medable’s agentic governance evolves with them.

Our continuous governance framework monitors agent performance throughout the lifecycle, helping teams identify changes, maintain oversight, and ensure agents continue performing as intended.

For clinical development, that means governance that isn’t frozen at deployment. It keeps pace with the agents themselves.

Our latest white paper explores how continuous governance enables clinical teams to scale agentic AI with ongoing performance monitoring, control, and traceability.

Access it here 👉 https://www.medable.com/knowledge-center/long-form-ensuring-clinical-trial-agent-performance-with-continuous-governance

As clinical trials extend beyond the traditional site, principal investigators are increasingly responsible for work car...
09/23/2026

As clinical trials extend beyond the traditional site, principal investigators are increasingly responsible for work carried out by people they don’t directly supervise or contract, including local providers, visiting nurses, and remote data collection vendors.

These external parties may perform trial activities, but accountability still sits with the investigator. Until now, there has been little practical guidance for navigating that gap.

Tomorrow, the MRCT Center and Medable will introduce 4 resources designed to address it:

→ Optimizing Decentralized Elements in Clinical Trials (DCTs): The sponsor's design tool for determining which activities are appropriate to move off-site.

→ Proportional Oversight Framework for Clinical Trials with Decentralized Elements: Translates those choices into a site-level approach calibrated to risk, rather than applying the same standard everywhere.

→ HCP Instruction Sheet: A model template, pre-filled by the sponsor and site, giving local providers clear direction on exactly what is expected of them.

→ HCP Check-In Questions for Participants: A consistent approach to understanding how participants are doing between visits, including worked responses across nine different scenarios.

This webinar will walk through each resource and, importantly, show how they work together to support decentralized trial delivery.

Each tool is designed for principal investigators, study coordinators, IRB reviewers, and sponsors incorporating hybrid and digital elements into their studies.

Register here to secure your spot: https://lp.constantcontactpages.com/ev/reg/6cj7t4q
________

Medable and the MRCT Center announce new resources for sponsors and investigators. These practical tools help determine ...
09/22/2026

Medable and the MRCT Center announce new resources for sponsors and investigators. These practical tools help determine which trial activities can appropriately take place closer to participants and establish the proportionate oversight, communication, and escalation processes needed to support them.

The decentralized model gained traction during the pandemic and has since evolved into a strategic priority for drug developers seeking to improve patient recruitment, retention, and diversity. In fact, trials incorporating decentralized components increased by nearly one-third from 2021 to 2022 alone.

👉 Learn more here: https://www.medable.com/newsroom/mrct-center-and-medable-launch-new-resources-for-investigator-oversight-in-decentralized-clinical-trials
________

For years, technology has improved individual parts of clinical development. But materially accelerating research requir...
09/18/2026

For years, technology has improved individual parts of clinical development. But materially accelerating research requires something bigger: changing how the entire system works together.

That’s the idea behind Medable’s 1:1:1 vision:

1-day study startup. 1-day patient enrollment. 1-year study conduct.

It’s an ambitious north star, but we’re already making measurable progress toward it. Study Studio dramatically compresses startup timelines and elevates data capture, while our AI agents address the whitespace during conduct by connecting systems, surfacing what matters, and executing defined work with human oversight.

Reaching 1:1:1 won’t hinge on a single breakthrough; we must systematically remove the friction that has slowed R&D for decades.

Learn more about the work underway at Medable here: https://www.medable.com/knowledge-center/blog-rapid-evolution-from-digitized-to-agentified-in-two-years
________

Address

Palo Alto, CA
94301

Website

Alerts

Be the first to know and let us send you an email when Medable posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share